Griseofulvinum
Griseofulvinum Brand names, Griseofulvinum Analogs
- Amudane
- Biogrisin-fp
- Curling factor
- Delmofulvina
- Fulcin
- Fulcine
- Fulvican grisactin
- Fulvicin
- Fulvicin P/G
- Fulvicin U/F
- Fulvicin-P/G
- Fulvicin-U/F
- Fulvina
- Fulvinil
- Fulvistatin
- Fungivin
- Greosin
- Gresfeed
- Gricin
- Grifulin
- Grifulvin
- Grifulvin V
- Gris-PEG
- Grisactin
- Grisactin Ultra
- Griscofulvin
- Grisefuline
- Griseo
- Griseofulvin [USAN:BAN:INN:JAN]
- Griseofulvin forte
- Griseofulvin-forte
- Griseofulvina [INN-Spanish]
- Griseofulvine [INN-French]
- Griseofulvinum
- Griseofulvinum [INN-Latin]
- Griseomix
- Grisetin
- Grisofulvin
- Grisovin
- Grisovin FP
- Grizeofulvin
- Grysio
- Guservin
- Lamoryl
- Likuden
- Likunden
- Murfulvin
- Neo-Fulcin
- Neocid
- Poncyl
- Spirofulvin
- Sporostatin
- Sporostatin xan
- Xuanjing
Griseofulvinum Brand Names Mixture
- No information avaliable
Griseofulvinum Chemical_Formula
C17H17ClO6
Griseofulvinum RX_link
http://www.rxlist.com/cgi/generic3/griseofulvin.htm
Griseofulvinum fda sheet
Griseofulvinum msds (material safety sheet)
Griseofulvinum Synthesis Reference
No information avaliable
Griseofulvinum Molecular Weight
352.766 g/mol
Griseofulvinum Melting Point
220 oC
Griseofulvinum H2O Solubility
8.64 mg/L
Griseofulvinum State
Solid
Griseofulvinum LogP
2.15
Griseofulvinum Dosage Forms
Powder; Tablet
Griseofulvinum Indication
For the treatment of ringworm infections of the skin, hair, and nails, namely: tinea corporis, tinea pedis, tinea cruris, tinea barbae, cradle cap or other conditions caused by Trichophyton or Microsporum fungi.
Griseofulvinum Pharmacology
Griseofulvin is a mycotoxic metabolic product of Penicillium spp. It was the first available oral agent for the treatment of dermatophytoses and has now been used for more than forty years. Griseofulvin is fungistatic with in vitro activity against various species of Microsporum Epidermophyton, and Trichophyton. It has no effect on bacteria or on other genera of fungi. Following oral administration, griseofulvin is deposited in the keratin precursor cells and has a greater affinity for diseased tissue. The drug is tightly bound to the new keratin which becomes highly resistant to fungal invasions.
Griseofulvinum Absorption
Poorly absorbed from GI ranging from 25 to 70% of an oral dose. Absorption is significantly enhanced by administration with or after a fatty meal.
Griseofulvinum side effects and Toxicity
Side effects are minor: headaches, gastrointestinal reactions and cutaneous eruptions
Griseofulvinum Patient Information
Griseofulvinum Organisms Affected
Yeast and other Trichophyton or Microsporum fungi
